Keywords: swiss, novartis, chooses, cambridge, usa, site, vaccines/diagnostics

Swiss Novartis chooses Cambridge, USA, as site for vaccines/diagnostics HQ

Article | 22 December 2006

Print This

Swiss pharmaceuticals giant Novartis says it has made significant progress in creating a new strategic growth platform in human vaccines, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in